El Nile Company for Pharmaceuticals and Chemical Industries SAE EGX:NIPH:
NILE PHARMACEUTICALS H1 NET PROFIT AFTER TAX EGP 170.1 MILLION
NILE PHARMACEUTICALS H1 REVENUE EGP 1.28 BILLION
Nile Pharmaceuticals H1 Profit EGP 170.1 Mln
El-Nile Co. for Pharmaceuticals & Chemical Industries on 6ix
Earlier from El-Nile Co. for Pharmaceuticals & Chemical Industries
- Nile Pharmaceuticals Board Elects Mohamed Abdel Aal El Sayed As Chairman
- Nile Pharmaceuticals Q1 Profit EGP 106.5 Mln
- Nile Pharmaceuticals Shareholders Approve FY Dividend EGP 2 Per Share
Later from El-Nile Co. for Pharmaceuticals & Chemical Industries
- Nile Pharmaceuticals Nine-Month Profit EGP 239.1 Million
- El-Nile Co. For Pharmaceuticals And Chemical Industries – El-Nile (NIPH.CA) Reports Year Ended 30/06/2026 Results
- Release from El-Nile Co. For Pharmaceuticals And Chemical Industries (NIPH.CA) Concerning the Invitation of the AGM
- El-Nile Co. For Pharmaceuticals And Chemical Industries (NIPH.CA) - Disclosure Form for the BoD & the Shareholders' Structure
- El-Nile Co. For Pharmaceuticals And Chemical Industries – El (NIPH.CA) - BoD Decisions
Follow El-Nile Co. for Pharmaceuticals & Chemical Industries into a list and get an email when it puts out news.
Follow El-Nile Co. for Pharmaceuticals & Chemical Industries